Lantheus Holdings (LNTH) Cost of Revenue (2014 - 2026)
Lantheus Holdings (LNTH) reported Cost of Revenue of $52.7 million for Q1 2026, up 23.95% year-over-year from $42.5 million in Q1 2025, and down 68.25% quarter-over-quarter from $165.9 million in Q4 2025.
Lantheus Holdings (LNTH) Cost of Revenue (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Cost of Revenue data on file, last reported at $52.7 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $52.7 million, up 23.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $404.5 million (up 338.13% YoY), and the FY2025 annual result was $599.7 million, up 237.0% from the prior year.
- Cost of Revenue retreated to $52.7 million in Q1 2026 per LNTH's latest filing, from $165.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $480.4 million in Q4 2023 and troughed at -$225.1 million in Q4 2024.
- A 5-year average of $100.7 million and a median of $91.9 million in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 1680.43% in 2023, then slumped 146.86% in 2024.
- A 5-year view of Cost of Revenue shows it stood at $27.0 million in 2022, then surged by 1680.43% to $480.4 million in 2023, then slumped by 146.86% to -$225.1 million in 2024, then soared by 173.7% to $165.9 million in 2025, then plunged by 68.25% to $52.7 million in 2026.
- Business Quant data shows LNTH's Cost of Revenue at $52.7 million in Q1 2026, $165.9 million in Q4 2025, and $48.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 11.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.68 Mn |
| Mar 31, 2026 | 52.68 Mn |
| Dec 31, 2025 | 165.91 Mn |
| Dec 31, 2025 | 165.91 Mn |
| Sep 30, 2025 | 48.83 Mn |
| Sep 30, 2025 | 48.83 Mn |
| Jun 30, 2025 | 137.03 Mn |
| Jun 30, 2025 | 137.03 Mn |
| Mar 31, 2025 | 42.50 Mn |
| Mar 31, 2025 | 42.50 Mn |
| Dec 31, 2024 | -225.11 Mn |
| Dec 31, 2024 | -225.11 Mn |
| Sep 30, 2024 | 136.61 Mn |
| Sep 30, 2024 | 136.61 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Mar 31, 2024 | 128.13 Mn |
| Mar 31, 2024 | 128.13 Mn |
| Dec 31, 2023 | 480.41 Mn |
| Dec 31, 2023 | 480.41 Mn |